Keflex and Aldomet drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Keflex (cephalexin) and Aldomet (methyldopa). Common drug interactions include depression among females and pulmonary artery stenosis congenital among males.
The phase IV clinical study analyzes what interactions people have when they take Keflex and Aldomet. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.
What is Keflex?
Keflex has active ingredients of cephalexin. It is often used in infection. eHealthMe is studying from 15,844 Keflex users. Check the latest studies of Keflex.
What is Aldomet?
Aldomet has active ingredients of methyldopa. It is often used in high blood pressure. eHealthMe is studying from 2,356 Aldomet users. Check the latest studies of Aldomet.
11 people who take Keflex and Aldomet together, and have interactions are studied.

What are the common drug interactions of Keflex and Aldomet, by gender? *:
female:
- Depression
- Sinus arrhythmia (a naturally occurring variation in heart rate that occurs during a breathing cycle)
- Sinus bradycardia (an unusually slow heartbeat due to heart disease)
- Palpitations (feelings or sensations that your heart is pounding or racing)
- Activities of daily living impaired
- Agitation (state of anxiety or nervous excitement)
- Akathisia (a movement disorder characterized by a feeling of inner restlessness)
- Angina pectoris (chest pain due to ischemia of the heart muscle)
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Aortic valve incompetence
male:
- Pulmonary artery stenosis congenital (congenital -narrowing (stenosis) that occurs in the lung artery)
- Pericardial effusion (fluid around the heart)
- Bradycardia (abnormally slow heart action)
- Deafness
- Urinary retention (the inability to completely or partially empty the bladder)
What are the common drug interactions of Keflex and Aldomet, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
- Cough
- Dyspnoea (difficult or laboured respiration)
20-29:
n/a
30-39:
n/a
40-49:
- Postmenopausal haemorrhage (post-menopausal bleeding)
- Pulmonary hypertension (increase in blood pressure in the lung artery)
- Rales (an abnormal respiratory sound characterized by fine crackles)
- Respiratory acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease)
- Restlessness (not able to rest)
- Sinus arrhythmia (a naturally occurring variation in heart rate that occurs during a breathing cycle)
- Sinus bradycardia (an unusually slow heartbeat due to heart disease)
- Sinusitis (inflammation of sinus)
- Skin ulcer
- Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
50-59:
n/a
60+:
- Drug hypersensitivity
- Abdominal pain upper
- Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
- Deafness
- Decreased activity
- Depression
- Diabetic vascular disorder (diseases of the blood vessels due to diabetes)
- Dizziness
- Dysaesthesia (abnormal sensation)
- Dysphagia (a condition in which swallowing is difficult or painful)
What are the existing conditions these people have? *
- Urinary Tract Infection: 4 people, 36.36%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 9.09%
* Approximation only. Some reports may have incomplete information.
Do you take Keflex and Aldomet?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Keflex and Aldomet:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Keflex:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Aldomet:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Keflex and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Aldomet and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Agrawal A, Rao M, Jasdanwala S, Mathur A, Eng M, "Cephalexin Induced Cholestatic Jaundice", Case reports in gastrointestinal medicine, 2014 Aug .
- Agrawal A, Rao M, Jasdanwala S, Mathur A, Eng M, "Cephalexin Induced Cholestatic Jaundice", Case reports in gastrointestinal medicine, 2014 Aug .
How the study uses the data?
The study uses data from the FDA. It is based on cephalexin and methyldopa (the active ingredients of Keflex and Aldomet, respectively), and Keflex and Aldomet (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Voltaren and Tofacitinib drug interactions for women aged 50-59 - 20 seconds ago
- Duloxetine Hydrochloride and Colitis Ulcerative for Men aged 30-39 - 24 seconds ago
- Duloxetine Hydrochloride and Uc for Men aged 30-39 - 24 seconds ago
- Duloxetine Hydrochloride and Inflammatory Bowel Disease - Ulcerative Colitis for Men aged 30-39 - 25 seconds ago
- Duloxetine Hydrochloride and Ulcerative Colitis for Men aged 30-39 - 25 seconds ago
- Could B12 cause Febrile Neutropenia? - 31 seconds ago
- Could Advil cause Hepatitis C? - 47 seconds ago
- Broken Bone and drugs of ingredients of atezolizumab - 50 seconds ago
- Could Neurontin cause Hepatitis A? - 50 seconds ago
- High Blood Pressure and drugs of ingredients of oxycodone hydrochloride - 51 seconds ago